Huapont Life Sciences Co.,Ltd. (SHE:002004)

China · Delayed Price · Currency is CNY

4.620

-0.030 (-0.65%)

May 22, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2019	FY 2019	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Jan '21 Jan 1, 2021	Dec '19 Dec 31, 2019	Jan '19 Jan 1, 2019	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Headquarters of The Group	83.18M	-	-	-	-
Tourism Department	1.23B	-	1.09B	-	513.76M
Tourism Department Growth	-	-	-	-	-12.22%
Other Business Units	184.70M	-	628.92M	813.64M	723.25M
Other Business Units Growth	-	-	-22.70%	12.50%	127.07%
Medicine Business	417.67M	-	265.62M	-	-
Pharmaceutical Division	3.30B	-	-	3.03B	3.00B
Pharmaceutical Division Growth	-	-	-	0.89%	7.99%
Agrochemical New Materials Division	6.50B	-	6.65B	8.95B	8.19B
Agrochemical New Materials Division Growth	-	-	-25.69%	9.27%	21.53%
Intersegment Offset	-206.23M	-	-	-	-
Pharmaceutical Raw Materials	-	-	2.96B	-	-
Hospitality	-	-	-	438.79M	-
Total	11.51B	-	11.59B	13.23B	12.43B
Total Growth	-	-	-12.38%	6.45%	15.83%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2019	FY 2019	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Jan '21 Jan 1, 2021	Dec '19 Dec 31, 2019	Jan '19 Jan 1, 2019	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Overseas	3.51B	3.59B	3.73B	5.42B	4.66B
Overseas Growth	-2.17%	-3.66%	-31.17%	16.35%	21.03%
China	8.00B	8.07B	7.87B	7.81B	7.77B
China Growth	-0.92%	2.63%	0.65%	0.51%	12.92%
Total	11.51B	11.66B	11.59B	13.23B	12.43B
Total Growth	-1.31%	0.60%	-12.38%	6.45%	15.83%

Source: S&P Global Market Intelligence.